← back to search

Beate Rau

Klinikum im Friedrichshain · DE
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Intraperitoneal and Appendiceal Malignancies, Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment, and Colorectal Cancer Surgical Treatments.
h-index
49
citations
10,168
works
403
NIH funding
primary concept
Medicine
email

Recent publications

Treatment Limitations and Missing Information in Peritoneal Metastatic Gastric Cancer.
2026cited by 0position: contributordoi
Peritoneal Surface Oncology surgery: Reflections on key determinants of success for female surgeons in this challenging discipline.
2026cited by 0position: contributordoi
The Regulatory Interplay of the Colorectal Cancer Biomarkers MACC1 and IER2 and Its Impact on Metastatic Cancer Survival.
2026cited by 0position: contributordoi
German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)
European Journal of Cancer 2025cited by 3position: middledoi
German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)
European Journal of Cancer 2025cited by 3position: contributordoi
Enhanced recovery for cytoreductive surgery and hyperthermic intraperitoneal Chemotherapy: An international survey to assess acceptance and feasibility
European Journal of Surgical Oncology 2025cited by 3position: contributordoi
European cancer workforce: under pressure.
2025cited by 1position: contributordoi
Pregnant Patients with Gastrointestinal Problems.
2025cited by 0position: contributordoi
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial.
2024cited by 82position: contributordoi
Review of 2022 PSOGI/RENAPE Consensus on HIPEC
Journal of Surgical Oncology 2024cited by 18position: middledoi
Review of 2022 PSOGI/RENAPE Consensus on HIPEC.
2024cited by 10position: contributordoi
Emerging Treatment Modalities for Gastric Cancer With Macroscopic Peritoneal Metastases: A Systematic Review.
2024cited by 4position: contributordoi
Morbidity and Mortality after Cytoreductive Surgery and HIPEC in a National Reference Center: A Six-Year Experience under Independent Evaluation.
2024cited by 3position: contributordoi
Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Can We Do Better?
2024cited by 3position: contributordoi
Hyperthermic intraperitoneal chemotherapy in colorectal cancer.
2024cited by 1position: contributordoi
Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative).
2024cited by 1position: contributordoi
[Gender medicine in peritoneal diseases].
2024cited by 0position: contributordoi
Reply to F. Salani et al.
2024cited by 0position: contributordoi
Allgemeinchirurgie
SOPs in Anästhesie, Intensivmedizin, Notfallmedizin und Schmerztherapie 2024cited by 0position: contributordoi
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial
Journal of Clinical Oncology 2023cited by 126position: firstdoi
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.
2023cited by 67position: contributordoi
Erkenntnisse der Gendermedizin – Relevanz für die Chirurgie?
2023cited by 1position: contributordoi
Synchronous Pleural and Peritoneal Mesothelioma: a Case Report and Narrative Review.
2023cited by 0position: contributordoi
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
The Lancet Oncology 2022cited by 101position: middledoi
HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques
Journal of Clinical Medicine 2022cited by 26position: lastdoi
Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study.
2022cited by 19position: contributordoi
HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques.
2022cited by 18position: contributordoi
S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus
Cells 2022cited by 10position: middledoi
Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas
Cancers 2022cited by 10position: middledoi
S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus.
2022cited by 10position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 29 papers (2020–2026)S Daum · LMU Klinikum14 papers (2018–2022)Michael Hummel · German Cancer Society11 papers (2018–2022)Ulrike Stein · German Cancer Research Center10 papers (2018–2022)Olivier Gléhen · Hospices Civils de Lyon10 papers (2020–2025)Erika Gebel Berg · Charité - Universitätsmedizin Berlin8 papers (2018–2022)Laurent VILLENEUVE · Centre Hospitalier Universitaire de Saint-Étienne8 papers (2020–2024)Christoph Treese · Franklin University8 papers (2018–2022)Moritz von Winterfeld · Heidelberg University8 papers (2018–2022)David L. Morris · Diabetes UK7 papers (2020–2022) · 6 papers (2021–2025)Pompiliu Piso · Wake Forest University6 papers (2020–2025)Andreas Brandl · Heidelberg University6 papers (2019–2022)Ulrike Stein · American Association for Cancer Research5 papers (2021–2026)Martin Hübner · Istituti di Ricovero e Cura a Carattere Scientifico5 papers (2020–2021)Andreas Brandl · Heidelberg University5 papers (2021–2024)Marcello Deraco · Fondazione IRCCS Istituto Nazionale dei Tumori5 papers (2021–2024)Alfred Königsrainer · University Children's Hospital Tübingen5 papers (2021–2021)Wolfgang Walther · German Cancer Research Center5 papers (2018–2022)Wim Ceelen · Istituti di Ricovero e Cura a Carattere Scientifico5 papers (2021–2022)